Measurement of Patient Reported Gastrointestinal (GI) and Health-Related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife).

Trial Profile

Measurement of Patient Reported Gastrointestinal (GI) and Health-Related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife).

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2009

At a glance

  • Drugs Mycophenolate sodium (Primary)
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 20 Oct 2009 Actual end date (Jan 2007) and actual number of patients (196) added as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top